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Abstract: There is a growing interest in determining fatty acid reference intervals from pregnancy
cohort, especially considering the lack of reference values for pregnant women in the literature
and the generalized misconception of equating reference intervals for nonpregnant women as
equivalent to pregnant women. Seafood and supplements are important dietary sources for the
omega-3 long-chain polyunsaturated fatty acids (ω-3 LCPUFA), such as eicosapentaenoic acid
(EPA, 20:5ω-3), docosapentaenoic acid (DPA, 22:55ω-3), and docosahexaenoic acid (DHA, 22:6ω-3).
Sufficient intake of EPA and DHA is vital during pregnancy for the development of the fetus, as well as
for maintaining adequate levels for the mother. This study describes the fatty acid status and suggests
reference values and cut-offs for fatty acids in red blood cells (RBC) from pregnant women (n = 247).
An electronic food frequency questionnaire (e-FFQ) mapped the dietary habits of the participants,
and gas chromatography was used to determine the fatty acid levels in RBC. The association between
e-FFQ variables and fatty acid concentrations was established using a principal component analysis
(PCA). Twenty-nine-point-one percent (29.1%) of the participants reported eating seafood as dinner
according to the Norwegian recommendations, and they added in their diet as well a high percentage
(76.9%) intake of ω-3 supplements. The concentration levels of fatty acids in RBC were in agreement
with those reported in similar populations from different countries. The reference interval 2.5/97.5
percentiles for EPA, DPA, DHA were 0.23/2.12, 0.56/2.80, 3.76/10.12 in relative concentration units
(%), and 5.99/51.25, 11.08/61.97, 64.25/218.08 in absolute concentration units (µg/g), respectively.
The number of participants and their selection from all over Norway vouch for the representativeness
of the study and the validity of the proposed reference values, and therefore, the study may be a
useful tool when studying associations between fatty acid status and health outcome in future studies.
To the best of our knowledge, this is the first PCA study reporting a direct association betweenω-3
LCPUFA and intake of seafood andω-3 supplements in a pregnancy cohort.
Keywords: fatty acid status; pregnancy; nutrition; biomarker; seafood intake;ω-3 supplement
1. Introduction
Nutrient deficiencies may lead to undesirable health outcomes. Pregnant women are considered
vulnerable, as the mother is the sole provider of nutrients for the fetus [1–3]. During pregnancy and
lactation, the maternal fatty acid status declines [4,5], which may lead to a suboptimal supply for the
fetus, principally in cases where the dietary intake of these fatty acids is low or absent. In addition,
Nutrients 2020, 12, 2950; doi:10.3390/nu12102950 www.mdpi.com/journal/nutrients
Nutrients 2020, 12, 2950 2 of 16
fatty acids are released from maternal adipose tissue stores to the fetus, especially docosahexaenoic
acid (DHA, 22:6ω-3), and marginally change blood levels [3,6]. The rapid growth of the fetal brain
during pregnancy and the first two years of childhood demand adequate levels of nutrients, such as the
omega-3 long-chain polyunsaturated fatty acids (ω-3 LCPUFA), eicosapentaenoic acid (EPA, 20:5ω-3),
and DHA. Experimental evidence suggests that DHA is the major structural and functional fatty
acid in the central nervous system [5,7]. Consequently, the maintenance of maternal fatty acid supply
is crucial.
Norway recommends a daily intake of 200 mg DHA for pregnant women [8]. Aquatic foods and
ω-3 supplements are the main dietary sources of EPA and DHA [9]. Pregnant women are advised
to follow the general dietary recommendations, which is to consume 300–450 g of fish per week,
corresponding to fish or fish products for dinner 2–3 times per week, of which a minimum of 200 g
should be fatty fish. There is inconsistency regarding the effects of DHA supplementation during
pregnancy and in the early phase of infant cognitive development. Some research suggests a beneficial
effect of DHA supplementation during pregnancy and/or lactation on mental development and on
long-term cognition [10]. However, the evidence on cognitive development is inconclusive [11–15].
Recent studies have also concluded that low levels ofω-3 LCPUFA in the blood are a risk factor for early
preterm birth and that an increased intake ofω-3 LCPUFA (via fish or supplements) is advisable [6,16].
Some studies suggested that pregnant and lactating women should consume 225–350 g (8–12 oz.)
per week (~250–375 mg/day of EPA and DHA) of a variety of seafood [17]. However, a study on DHA
and the increased risk for early preterm birth recommends a range of 600–800 mg/day of DHA for
women with levels of DHA in red blood cells (RBC) lower than 5% [6]. Some authors who support
the supplementation ofω-3 LCPUFA as an effective strategy for reducing preterm birth advise that a
follow-up of completed trials is needed to assess long-term outcomes [18]. Lands and collaborators
emphasize that careful handling of data on fatty acid composition is needed when interpreting evidence
of dietary fatty acids on health outcomes [19].
Determination of fatty acid levels in RBC is a well-known approach for assessing fatty acid status
as it reflects the last 30–60 days of intake [20]. EPA and DHA, accompanied by some other fatty acids,
for example, short-chain fatty acids present in milk, are indirect biomarkers of specific foods as these
foods are the primary dietary source of the respective fatty acids [21].
Reference intervals provide information on specific biomarkers in population-based cohort studies
and offer a clear understanding of the initial status, as well as provide the basis for comparison
over time. Most laboratories and scientific reference tables offer information derived from healthy
nonpregnant women, but lack reference intervals for pregnant women. During pregnancy, there are
changes in many biological markers, and therefore, reliable reference values derived from a healthy
pregnant population are of importance for correct clinical decisions. Without adequate reference
intervals, there is an increased risk of missing important changes, due to pathological conditions
and to erroneously interpretation of normal changes as pathological events [22]. Hence, reference
intervals are the most widely used tool for medical decision-making, therapeutic management decisions,
and other physiological assessments [23,24]. The present study aims at suggesting reference intervals
and cut-offs for fatty acids in maternal RBC on a sufficiently large healthy population that can be
used in future studies to identify women who are at risk of adverse health outcomes as a result of
under or overexposure to fatty acids. In addition, the relationship between the intake of seafood and
ω-3 LCPUFA, generally characterized as poor in many pregnancy cohort studies [25,26], is thoroughly
investigated using a principal component analysis.
2. Materials and Methods
2.1. Study Design
The present research is based on data from the national Little in Norway (LiN) cohort project
(ISRCTN registry number 66710572) that is a cross-disciplinary prospective longitudinal study starting in
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pregnancy. The overall study design for the LiN-cohort has been described in more detail elsewhere [27].
The LiN-cohort included nine health care centers from northern, mid, western, and eastern Norway
(Table 1).
Table 1. Background characteristics of the population.










<4 years of higher education † 60.7
≥4 years of higher education 39.3
Marital status
Living with partner/married 96.8
Not living with partner/other 3.2
Use of smoke/snuff tobacco during pregnancy
Yes 6.5
No 93.5





* mean ± standard deviation; ** BMI estimated for n = 202; † University or University College.
The study was conducted from September 2011 to October 2012 according to the guidelines laid
down in the Declaration of Helsinki. The procedures involving human subjects were approved by the
Regional Committees for Medical and Health Research Ethics in Norway (REK 2011/560). Informed
written consent was obtained from all subjects participating in the study. The flow of participants and
data relevant for this research is outlined in Figure 1.
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2.2. Population
Pregnant women (n = 247), at different gestational periods and from different geographical regions
in Norway (Figure 2), were recruited and their blood collected at the first prenatal appointment in the
health centers. The characteristics of the population, including age, gestational weeks, and demographic
information is presented in Table 1.
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2.3. Dietary Assessment
The validated electronic semi-quantitative food frequency questionnaire (e-FFQ) [28] was
implemented on 203 out of the 247 participants to determine the dietary intake of seafood between
gestational weeks 16 and 32. The e-FFQ considers questions, such as “How often have you consumed
fish, fish products or other seafood as lunch, spread or snack meal during the last three months?” and
also a question regarding intake of ω-3 supplements, with the alternatives “yes” and “no”. The e-FFQ
was designed to capture the whole seafood diet, including seafood from all meals during the day [28].
Educational level, demographic information, and tobacco use questions are also included in the e-FFQ.
The participants were anonymized by giving a unique ID number and corresponding password for
entering the electronic questionnaire. It is important to mention that before starting the LiN project,
all the available brands of omega-3 supplements in Norway were analyzed, and the results were
published elsewhere [29]. The fatty acid composition in mg/capsule of the different brands of ω-3
supplements that were consumed by the participants is reported in Table S1. The declared content of a
capsule was always 1 g of oil. The minimum/maximum levels of EPA, DPA, DHA, and EPA+DHA in
mg/capsule were 174.55/282.65, 25.05/41.45 167.60/190.75, and 349.65/457.00, respectively (Table S1).
2.4. RBC Collection
The sample collection procedure has been described elsewhere [4]. Briefly, non-fasting venous
blood samples from the participants were collected by venepuncture in 4 mL BD Vacutainer K2EDTA
(7.2 mg) vials (Becton, Dickinson and Company, Franklin Lakes, USA) at the first prenatal appointment.
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The vials were centrifuged (1000–1300× g, 20 ◦C, 10 min) within 30 min. The RBC were adequately
separated from plasma and buffy coat to ensure a clean RBC fraction. The samples were stored at the
sites of the collection at −18 ◦C for up to a maximum of four weeks, and thereafter shipped to the
Institute of Marine Research (IMR) in Bergen, Western Norway, for further storage at −80 ◦C prior
to analysis. Regarding the stability of the fatty acids in the RBC samples, some studies recommend
temperatures between 1 ◦C and 6 ◦C to preserve RBC quality for up to 42 days [30]. In addition,
a recent pilot biobank study, at IMR, demonstrated that fatty acid profiles from RBC, with or without
antioxidants, remain stable for up to 13 weeks at −20 ◦C and −80 ◦C [31].
2.5. Fatty Acids
The preparation of the fatty acid methyl ester (FAME) is an accredited method granted by
the Norwegian Accreditation Authority and published elsewhere [32]. Briefly, 50 µL of the RBC
sample was mixed with 2 mL BF3 in methanol, and 5 µg of 19:0 internal standard. The mixture was
heated at 100 ◦C for 1 h and cooled until it reached room temperature. Aliquots of 1 mL of hexane
and 2 mL of H2O were added, vortex-mixed for 15 s, placed in a centrifuge at 1620× g for 2 min,
and the hexane phase (containing the FAME) was collected, evaporated under nitrogen, dissolved in
hexane, and submitted to gas chromatography analysis at IMR on a Perkin-Elmer AutoSystem XL gas
chromatograph (Perkin-Elmer, Norwalk, CT, USA) equipped with a liquid autosampler and a flame
ionization detector. The FAME samples were analyzed on a CP-Sil 88 capillary column (50 m × 0.32 mm
I.D. 0.2 µm film thickness, Varian, Courtaboeuf, France). Data collection was performed by the
Perkin-Elmer TotalChrom Data System software version 6.3 (Perkin-Elmer, Somerset, MA, USA).
The temperature program was as follows: The oven temperature was held at 60 ◦C for 1 min, ramped
to 160 ◦C at 25 ◦C/min, held at 160 ◦C for 28 min, ramped to 190 ◦C at 25 ◦C/min, held at 190 ◦C for
17 min, ramped to 220 ◦C at 25 ◦C/min and finally held at 220 ◦C for 10 min. The direct on-column
injection was used. The injector port temperature was ramped instantaneously from 50 to 250 ◦C,
and the detector temperature was 250 ◦C. The carrier gas was ultra-pure helium at a pressure of 82 Kpa.
The analysis time was 60 min. This time interval was sufficient to detect FAME with chains from 10 to
24 carbons in length. The FAME peaks were identified by comparing their retention times with the
retention times of highly purified FAME standards. The fatty acid results were expressed as relative
(%) and absolute (mg/g RBC wet weight) units. The omega-3-index was calculated as the sum of EPA
and DHA in relative units (Σ(%EPA + %DHA) [33].
2.6. Statistics
An Excel-based platform (Table S2) was developed for the automatic analysis of the
chromatographic data. The Excel-based platform consists of three workbooks: (1) Data entry, where a
maximum of five fatty acid concentration profiles can be entered; (2) FA distribution per station,
where the distributions of the different fatty acids at the different health care stations are displayed
automatically; (3) total FA distribution, to visualize automatically whether the total number of measured
concentrations (n = 247) for specific fatty acids are normally distributed. The percentiles of the fatty
acids were derived from the normal distribution. After transforming the e-FFQ nominal variables
into numerical values, they were submitted to principal component analysis (PCA) along with the
chromatographic data to detect meaningful relationships between the different fatty acids and the intake
of seafood and ω-3 supplements. Statgraphics Centurion XVI (Version 16.1.11, StatPoint Technologies,
Inc., Warrenton, VA, USA) was used for data analysis.
3. Results
3.1. Characterization of Study Population
Demographic information of the population, such as age, gestation period, body mass index
(BMI), education, marital status, smoking habits (Table 1), and geographical region (Figure 2), are
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described. The different characteristics were estimated from the total number of participants (n = 247),
except the BMI values that were estimated from 202 participants and categorized as underweight
(3.5%), normal weight (68.8%), and overweight (27.7%). All the participants attended university or
university college, and the majority of them (86.2%) were located in geographical regions under
Northern Norway (13.8%) (Table 1, Figure 2).
3.2. Seafood Intake
The results of the e-FFQ (Table 2) revealed that 76.4% (47.3 + 29.1) of the pregnant women consumed
seafood as dinner with a frequency of 1–3 times/week. However, only 29.1% of the participants were
following the Norwegian recommendations of seafood intake as dinner 2–3 times/week (Table 2).
A percentage of 4.4% of the population reported a frequency intake of seafood as dinner lower than
once a month, and from this group of participants, only 2.5% reported consumingω-3 supplements.
For the intake of seafood as spread or snack, similar frequencies were reported for 1–3 times per month
(27.6%) and 1–2 times per week (29.1%), and they were ascribed to a relatively high intake of bread and
spread in Norway. These particular frequency groups, reported the highest intake ofω-3 supplements,
20.2% (1–3 times per month) and 24.6% (1–2 times per week).
Table 2. Intake frequencies for seafood as dinner, seafood as spread/snack and omega-3 (ω-3)
supplements among Norwegian pregnant women (n = 203). Unbracketed and bracketed figures





Seafood as dinner Yes No
<1time/month 1 9 (4.4) 5 (2.5) 4 (2.0)
1–3 times/month 2 35 (17.2) 27 (13.3) 8 (3.9)
1 time/week 3 96 (47.3) 74 (36.5) 22 (10.8)
2–3 times/week 4 59 (29.1) 46 (22.7) 13 (6.4)
≥4 times/week 5 4 (2) 4 (2.9)
Seafood as spread or snack
Never 1 24 (11.8) 15 (7.4) 9 (4.4)
Rare 2 45 (22,2) 35 (17.2) 10 (4.9)
1–3 times/month 3 56 (27.6) 41 (20.2) 15 (7.4)
1–2 times/week 4 59 (29.1) 50 (24.6) 9 (4.4)
3–5 times/week 5 17 (8.4) 15 (7.4) 2 (1.0)
≥5 times/week 6 2 (1) 2 (1.0)
Totalω-3-supplement intake 0 or 1 156 (76.9) 47 (23.2)
* PCA: principal component analysis.
3.3. Fatty Acid Status
A total of 247 fatty acid concentration profiles were estimated from seven health stations (two out
of the total nine health stations lacked facilities for blood collection and sample preservation) and
reported in both relative (%) and absolute (mg/g) units (Table S3). The relative concentrations of
the fatty acids (14:0, 16:0, 18:0, 22:0, 16:1, 18:1, 24.1ω-9, 18:2ω-6, 20:3ω-6, 20:4ω-6, 22:4ω-6, 18:3ω-3,
20:5ω-3, 22:5ω-3 and 22:6ω-3) at the different health stations were normally distributed. After
demonstrating data normality at the different stations, the concentrations of the different fatty acids
(unsaturated, monounsaturated, and polyunsaturated) were added together, and graphs of the
probability density function against the concentration of fatty acid in the relative unit (%) were plotted
(Figure 3) and used for computing the corresponding percentiles (Table 3). Although the distributions
of the fatty acids in mg/g units are not shown, they were also normally distributed. The reader can
automatically generate the normal distributions (for % or mg/g) by copy-pasting the experimental
results in Table S3 into the provided calculation platform in Table S2.
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Table 3. Percentiles for selected fatty acids in red blood cells from pregnant women (n = 247) were recruited all over Norway.
Percentiles (%) Percentiles (µg/g)
Mean 2.5 5 10 25 50 75 90 95 97.5 Mean 2.5 5 10 25 50 75 90 95 97.5
%
14:0 0.65 0.27 0.35 0.39 0.49 0.62 0.77 0.96 1.11 1.22 14.75 7.14 7.48 8.68 10.38 13.48 17.33 22.24 26.97 30.66
16:0 23.10 20.60 20.83 21.19 21.72 22.70 23.68 25.51 26.96 29.62 509.41 400.25 413.49 430.96 458.06 500.95 548.11 599.90 623.18 652.36
18:0 14.12 11.72 12.22 12.56 13.16 14.04 14.82 15.55 16.85 18.82 308.39 266.68 277.86 282.71 290.24 307.58 324.14 339.64 348.88 359.40
22:0 0.63 0.31 0.34 0.40 0.50 0.61 0.74 0.86 0.94 1.00 13.79 7.26 8.24 9.34 11.18 13.73 16.30 18.46 19.91 21.21
16:1 1.04 0.36 0.51 0.65 0.84 0.98 1.20 1.50 1.67 1.90 23.58 7.54 10.33 13.27 17.08 21.07 27.79 35.97 43.36 47.43
18:1 16.71 14.00 14.45 14.80 15.45 16.58 17.63 18.88 19.68 20.18 371.49 264.10 280.12 298.38 319.83 358.57 409.14 476.29 510.59 536.99
24:1ω-9 1.75 0.88 1.07 1.17 1.34 1.64 2.01 2.50 2.76 3.13 38.07 20.36 22.90 25.49 30.42 36.73 44.04 51.83 57.73 64.76
18:2ω-6 11.98 8.34 9.01 9.52 10.55 11.52 13.13 14.74 16.10 17.08 268.62 160.28 173.28 191.40 220.38 255.68 301.01 359.55 402.95 453.61
20:3ω-6 1.57 0.93 1.06 1.14 1.35 1.56 1.76 2.05 2.19 2.41 35.03 17.29 20.70 24.04 29.43 34.13 40.77 46.03 49.96 54.82
20:4ω-6 10.84 5.05 6.87 8.56 9.95 11.28 12.11 12.77 13.14 13.52 240.27 92.32 135.45 182.19 223.29 247.75 273.12 289.50 297.74 313.66
22:4ω-6 1.64 0.41 0.69 0.91 1.31 1.67 2.03 2.31 2.44 2.62 36.31 10.00 13.49 20.00 28.77 37.33 45.15 50.55 55.20 57.91
18:3ω-3 0.29 0.13 0.15 0.17 0.21 0.27 0.35 0.44 0.51 0.54 8.70 5.14 5.32 5.51 6.50 9.49 10.00 10.63 12.27 13.52
20:5ω-3 0.79 0.23 0.27 0.32 0.45 0.64 1.01 1.33 1.82 2.12 17.86 5.99 6.61 7.83 10.00 15.06 22.17 29.85 40.73 51.25
22:5ω-3 1.79 0.56 0.83 1.26 1.53 1.82 2.09 2.36 2.65 2.80 39.71 11.08 17.34 28.62 34.32 40.41 45.75 52.72 55.66 61.97
22:6ω-3 6.92 3.76 4.18 5.14 5.98 6.94 7.86 8.63 9.38 10.12 152.74 64.25 82.84 114.74 135.66 153.41 172.38 194.38 209.45 218.08
Omega-3 Index * 7.71 4.14 4.66 5.53 6.60 7.70 8.86 9.87 10.67 11.90
ω6/ω3 2.71 1.63 1.85 1.97 2.29 2.65 3.03 3.54 3.76 3.93
Totalω-6 26.65 17.83 21.01 23.44 25.62 27.16 28.52 29.74 30.34 30.85
Totalω-3 10.24 5.68 6.28 7.85 8.89 10.32 11.67 12.66 13.33 15.14
* Omega-3 Index is defined as the summation of 20:5ω-3 and 22:6ω-3.
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The most concentrated saturated, monounsaturated,ω-6 polyunsaturated fatty acids (PUFA) and
ω-3 PUFA in Table 3 were 16:0, 18:1, 18:2ω-6, and 22:6ω-3, respectively. The computed median/average
ratios for these major fatty acids were 0.98 (22.7/23.1), 0.99 (16.6/16.7), 0.96 (11.5/12.0), and 1.00 (6.9/6.9)
in % units and 0.98 (500.9/509.4), 0.97 (358.6/371.5), 0.95 (255.7/268.6), and 1.00 (153.4/152.7) in µg/g
units. Similarly, the rest of the fatty acids exhibited mean/average ratios close to 1.00, indicating that
the graph’s probability density versus concentration (Figure 3) provides a good approximation of the
sampling distribution of the fatty acid of interest. A comparison of the results in Table 3 with those
reported in similar studies was performed, and presented in Table 4.
The PCA of the e-FFQ and fatty acid data was performed after transforming the e-FFQ nominal
data into numerical variables. The transformation consisted of assigning scores of 1 (lowest frequency),
5 or 6 (highest frequency) to the seafood frequency, and scores of 0 (negative answer) or 1 (affirmative
answer) to the intake ofω-3 supplements (Table 2). The PCA revealed a positive correlation between
EPA (20:5ω-3), docosapentaenoic acid (DPA, 22:5ω-3), DHA (22:6ω-3), the intake of seafood (designated
as WI and WII variables in Figure 4) and the intake ofω-3 supplements (designated as WIII variable in
Figure 4). These variables (EPA, DPA, DHA, WI, WII, WIII) are close to each other (framed in black
in Figure 4) and display negative PC3 values. In contrast, the ω-6 PUFA, more specifically 20:3ω-6,
20:4ω-6, and 22:6ω-3 (framed in green in Figure 4) do not correlate with the e-FFQ variables and
display positive PC3 values, which in turn discriminates theω-3 PUFA. Linoleic acid (LA, 18:2ω-6) and
alpha linolenic acid (ALA, 18:3ω-3) emerge as a cluster (framed in blue in Figure 4) and do not exhibit
any association with theω-6 andω-3 PUFA or any of the studied e-FFQ variables. The remaining fatty
acids were independent of the intake of seafood orω-3 supplements, as observed in Figure 4.
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Figure 4. Principal components 1, 2 and 3 (PC1, PC2 and PC3, respectively) to study the correlation
between selected fatty acids in maternal red blood cells and electronic food frequency questionnaire
(e-FFQ) variables (WI = seafood as dinner, WII = seafood as spread or snack, WIII =ω-3 supplements)
as. There is an association between 20:5ω-3 (EPA), 22:5ω-3 (DPA), 22:6ω-3 (DHA) and WI, WII, WIII
(black frame), while theirω-6 counterparts (green frame) and essential fatty acids (blue frame) do not
correlate with the e-FFQ variables.
4. Discussion
The applied e-FFQ was not focused onω-3 fatty acids originating from plants, but from the habitual
intake of seafood (fish and shellfish) and the use of dietary supplements, because the endogenous
metabolization of ALA (18:3 n-3) from plants to ω-3 PUFA (e.g., EPA, DPA, and DHA) is minimal.
Furthermore, the e-FFQ considered different forms of seafood individually. For example, the indexes
for dinners were grouped into five categories comprising dinner items of oily fish, lean fish, shellfish,
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processed fish, and freshwater fish. Additionally, freshwater fish consumption was divided into two
separate questions, frequency of perch/pike (lean fish) and frequency of char/whitefish (oily fish) [28].
The e-FFQ indicated that 29.1% of the participants reported an intake of fish for dinner that was
in accordance with dietary guidelines from the Norwegian Directorate of Health (Table 2). However,
a high percentage of participants from all the assessed groups (under and over seafood as dinner
2–3 times/week) reported the intake of ω-3 supplements. In addition, it was remarkable that the
intake ofω-3 supplements was almost identical (around 77%) for all the observed groups, 1–3 times
per month (27/35 × 100 = 77.14%), one time per week (74/96 × 100 = 77.08%) and 2–3 times per
week (46/59 × 100 = 77.97%), as shown in Table 2. The high intake of omega-3 supplements in this
particular cohort of Norway is in accordance with global awareness towards the beneficial effects
of these dietary products as they improve the levels of omega-3 PUFA by covering dietary seafood
shortfalls, particularly for those who dislike the taste or smell of fish.
The observed frequencies for gestational weeks 16 and 32 of 68.97, 29.06 and 76.85% for the
categories seafood intake under dietary guidelines (n = 140), 2–3 times/week (n = 59) and intake ofω-3
supplements (n = 156), respectively (Table 2) are consistent with those reported for gestational week 22
and 32 by The Norwegian Mother and Child Cohort Study (n = 67007) of 60.06, 23.47 and 63.95 for the
categories seafood intake under 2–3 servings/week (n = 40244), seafood intake of 2–3 servings/week
(n = 15724) and intake ofω-3 supplements (n = 428852), respectively [34]. In addition, the observed
29.06% frequency (for those Norwegian pregnant women (30.1 ± 4.6 years) in accord with the national
dietary guidelines), is in close agreement with the latest national dietary survey conducted among
adults in Norway (2010–2011) where women in the age group 30–39 reported a frequency of 21% for
the intake of seafood for dinner three times per week or more [35]. The agreement with previous
studies confirms the robustness of the semi-quantitative e-FFQ to assess the dietary intake of seafood
andω-3 supplements.
The PCA plot (Figure 4) detected a correlation between theω-3 PUFA and the e-FFQ variables,
and it discriminated the ω-6 and ω-3 PUFA into three clusters that can be intuitively explained,
as follow: The concentration levels of 20:3ω-6, 20:4ω-6, and 22:4ω-6 (inside the green frame in Figure 4)
and 20:5ω-3, 22:5ω-3 and 22:6ω-3 (inside the black frame in Figure 4) reflect both endogenous (de novo
lipogenesis) and exogenous (dietary intake) sources; whereas, the concentration levels of essential fatty
acids, such as 18:2ω-6 and 18:3ω-3 (inside the blue frame in Figure 4), exclusively reflect the dietary
intake of the participants. In addition, Figure 4 reveals that neither 18:2ω-6 nor 18:3ω-3 are correlated
with any of the e-FFQ variables.
The associations between qualitative variables (e.g., frequency of consumption of fish, BMI,
ethnicity, etc.) and fatty acids in plasma from pregnant adolescents (14–18 years old) by using PCA
has been published elsewhere [36]. Although this particular study did not discuss in detail the PCA
results, an analysis of its reported PC1 and PC2 loadings revealed that the association 20:4ω-6/fish was
stronger than the associationω-3 PUFA/fish (e.g., 18:3ω-3, EPA, DPA); and also the lack of correlation
between essential fatty acids (e.g., 18:3ω-3, 18:2ω-6) which should exclusively reflect the dietary
intake. In general, studies on the association between food intake variables from FFQ and fatty acids
from pregnant women, by using techniques different to PCA, have consistently demonstrated poor
correlations between dietary fatty acid intake and blood levels [25,26]. The present pregnant cohort
study is the first to report a clear association between e-FFQ variables and fatty acids in RBC from the
pregnant cohort by using PCA.
Except for 18:2ω-6, the sequence of most concentrated fatty acids reported in the present study
(16:0, 18:1, 18:2ω-6, 22:6ω-3) has been also observed in studies with pregnant women from Belgium [37],
Netherlands [38], Germany [39], and Japan [40,41]. In these countries, the major ω-6 PUFA was
20:4ω-6, and its level was consistently higher than 18:2ω-6 by 69.6, 2.8, 1.0, and 28.2% (average from
References [40,41]), respectively; whereas, in the present study 20:4ω-6 was lower than 18:2ω-6 by
9.5%. Possible explanations behind the observed reduction in the present study might be the high
intake ofω-3 supplements (76.9%) compared to the studies from Belgium (24.6%), Netherlands (14.3%),
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Germany (20%), and Japan (2.2% in Reference [41]). In addition, an analysis of the estimated global
seafood consumption per country [42] by the time these specific studies were performed indicated that
Norway had the highest seafood consumption per capita (52.9 Kg in 2012) compared to Belgium (23.8 Kg
in 2016), Netherlands (22.11 Kg in 2000), Germany (14.3 Kg in 2011) and Japan (48.6 Kg in 2013).
In the present study, theω-3 PUFA sequence ranked from lowest to highest concentration was
18:3ω-3, 20:5ω-3, 22:5ω-3, and 22:6ω-3. This specific sequence is in agreement with similar studies
from the Netherlands [38], Germany [39], and Japan [41]. Other studies from Japan [40], Belgium [37],
and Iceland [43] have not reported the concentration levels of 18:3ω-3 or 22:5ω-3. However, in these
studies, the declaredω-3 PUFA followed the aforementioned order.
In general, the range of concentrations for selected fatty acids in RBC from pregnant women
in Table 3 is in agreement with reported median or average values in similar studies from different
countries, as indicated in Table 4 in green color. However, in some countries, the levels of particular
fatty acids were distinct from the 2.5 or 97.5 percentiles of the present study, as indicated in Table 4 in
yellow and red colors, respectively. The reasons behind the observed discrepancies are beyond the
scope of the present article.
Table 4. A comparison of reported mean [37–39,43] or median [40,41] concentrations (%) of fatty acids
in different countries with those selected in the present study. The symbol × indicates that the fatty acid
is not reported in the particular reference number. The green, yellow and red colors denote: Between
2.5 and 97.5 percentiles, under 2.5 percentile and over 97.5 percentile of the present study, respectively.
Belgium [37] Iceland [43] Germany [39] Japan [41] Netherland [38] Japan [40]
14:0 × × ×
16:0 × ×
18:0 × ×
22:0 × × × ×
16:1 × × × ×
18:1 × ×









Some studies have indicated that values ≥8% or <5% are associated with the lowest risk for
cardiovascular events [44] or the highest risk of depressive episodes [45], respectively. Despite these
observations, an optimal range of omega-3 index for pregnant women has not been defined yet.
A recent study has indicated that no human being has an omega-3 index <2% [44]. Contrary to this
observation, in the present study that involved only healthy pregnant women, a participant (hereinafter
referred to as p#159) with an omega-3 index of 1.93% was recorded. The relative concentrations of EPA
(0.43%) and DHA (1.50%) for p#159 were allocated inside the range and under the lowest percentiles
for these fatty acids (Table 3). In addition, p#159 exhibited the largest DPA concentration level (3.59%).
A close inspection of the same fatty acids in µg/g units for p#159 revealed that EPA, DHA, and DPA
were allocated in the 55, 35, and 55 percentiles, respectively, and consequently, the values in µg/g units
are inside the range of the studied population. It is equally important to mention that theω-6/ω-3 index
is another key player in epidemiological studies that are generally associated with depression [45] and
cardiovascular events [46]. Some studies have indicated thatω-6/ω-3 >9 is associated with postpartum
depression [47]; whereas, an ω-6/ω-3 around 4 exerts cardioprotective effects [46]. Experimental
evidence suggests that the optimumω-6/ω-3 ratio must be kept around 4 and 5 and should not exceed
10 [48]. The computedω-6/ω-3 ratio for p#159 was 3.84 (95 percentile in Table 3), and it can be regarded
as optimum. The previous observations about the different indexes and measurement units, do not try
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to draw general conclusions based on the results of just one participant, but to highlight the importance
of a comprehensive evaluation of the implications in human health of the different indexes and their
corresponding threshold not only from the perspective of relative units (%), but also absolute units
(mg/g). In addition, it is important to highlight that published randomized trials have not provided
conclusive evidence yet about the effect ofω-3/ω-6 PUFA on postpartum depression.
In the present research, 42% of the pregnant women had an omega-3 index above 8%.
It was mentioned that this index plays a pathophysiologic role in depressive symptoms [45,49,50].
The International Society for Nutritional Psychiatry Research Practice Guidelines forω-3 fatty acids
has recently recommended therapeutic dosages of pure EPA or a combination of EPA and DHA
(with net EPA starting from at least 1 up to 2 g/day) for at least eight weeks as a potential treatment for
major depressive disorders [51]. We have previously shown that low omega-3 index in pregnancy is
a possible risk factor for postpartum depression [52], with a cut-off at 4%. This cut-off is similar to
the 2.5 percentile in Table 3 and in accordance with the cut-off for those at high risk of developing
coronary heart disease [53]. Thus, the suggested reference values and omega-3 index cut-off could help
to identify women who might benefit from increasing the dietary intake of EPA and DHA, like seafood
and supplements that are important dietary sources of these long-chain PUFA, and hence, will influence
their nutritional status. It must be mentioned that there are no specific recommendations on the intake
of EPA or DHA for the general population, including prenatal women, in Norway [54].
Cohort studies for establishing national reference intervals for fatty acids in RBC of pregnant women
are largely dependent, among other things, on the number of participants, the number of health stations,
the geographical distribution of the health stations along with their inherent infrastructure for collecting
and preserving samples long-term at appropriate temperatures. For instance, fatty acids in RBC are
susceptible to degradation and remain stable for 42 or 91 days at 1 ◦C or −20◦C, respectively [30,31].
Failure to comply with these requirements might be regarded as a drawback. Some of the apparent
limitations of the present study are the lack of blood collection/preservation facilities (namely seven
well-equipped facilities). However, most of the studies in Table 4 were performed in one specific
geographical region by using just one blood collection facility. In some cases, the selected geographical
regions represented a very low percentage of the total female population of the country in question.
For example, the studies from Belgium [37], the Netherlands [38], and Germany [39] represented
~1.71, ~0.71%, and ~0.13% of the total female population, respectively. Moreover, the studies from
Iceland [43] and Japan [40,41] constituted approximately 33.73 and 18.23% of the total female population,
respectively, they were carried out in specific regions (Reykjavik and the Miyagi Prefecture), and they
do not contain all the important characteristics of the country population from which they were drawn.
The present study collected samples from the main geographical regions of Norway, which account for
a ~91.5% of the targeted population. In addition, the present study with seven collection facilities has a
higher level of enrolment per thousand pregnant women than Japan with 15 collection facilities, namely,
4.16% and 1.63% by the time these specific studies were performed, respectively. The expression
n = N/[1 + N(e/100)2] (aka Slovin formula) [55], that is generally considered to estimate the sample size
(n) given the population size (N) and a percentage of margin error (e) was used to judge whether n = 247
was an appropriate sample size. By the time the samples were collected (2011–2012), the parameter
N was estimated using the Statistics Bureau of Norway’s records of the average number of births
(59410± 10) between 2011–2012 [56], while the parameter e was set at 7.5% (half the maximum margin of
error of 15% proposed by IUPAC for monitoring fatty acid concentrations by gas chromatography [57]).
A minimum value of n = 177 was calculated by introducing the aforementioned parameters in the
Slovin expression, which in turn concluded that the sample size of the present research (n = 247)
was sufficient to determine reliable reference intervals for fatty acids in maternal RBC. An important
feature of a selected sample size should be its ability to make projections or generalizations regarding
an entire population. The information in Table 1 and Figure 2 indicates that pregnant women were
recruited from all over the Norwegian territory, which emphasizes the strength and representativeness
of the sample size, and consequently, the validity of the proposed reference values in the present
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study. The previous observations indicate that there is not any suspicion of misrepresentation of the
population of interest in the present study.
5. Conclusions
Reference intervals and cut-offs for fatty acids in RBC from a pregnancy cohort from all over
Norway and in agreement with those reported in other countries were established. A direct association
between ω-3 LCPUFA (EPA, DPA, DHA, but not ALA) in maternal RBC and the intake of seafood
and ω-3 supplements was found. The findings from the e-FFQ were in accordance with national
surveys and highlighted the awareness of the participants about the importance of dietary ω-3 in
maternal health. Given the importance of seafood and ω-3 supplements during pregnancy, further
studies are warranted to investigate comprehensively the impact on the health of the various indexes
(e.g., omega-3 index,ω6/ω3) associated with fatty acid status and by using relative and absolute units.
The proposed reference intervals in RBC may be a useful tool when studying associations between
fatty acids and health outcomes.
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